請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43089
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 符文美 | |
dc.contributor.author | Chia-Sheng Kuo | en |
dc.contributor.author | 郭嘉盛 | zh_TW |
dc.date.accessioned | 2021-06-15T01:36:22Z | - |
dc.date.available | 2009-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-16 | |
dc.identifier.citation | Reference
Adler LE, Hoffer LD, Wiser A, Freedman R (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861. Agulhon C, Abitbol M, Bertrand D, Malafosse A (1999) Localization of mRNA for CHRNA7 in human fetal brain. Neuroreport 10:2223-2227. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jr., Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266. Amunts K, Kedo O, Kindler M, Pieperhoff P, Mohlberg H, Shah NJ, Habel U, Schneider F, Zilles K (2005) Cytoarchitectonic mapping of the human amygdale, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol (Berl) 210:343-352. Anand R, Conroy WG, Schoepfer R, Whiting P, Lindstrom J (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J Biol Chem 266:11192-11198. Arnsten AF, Ramos BP, Birnbaum SG, Taylor JR (2005) Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11:121-128. Banerjee C, Nyengaard JR, Wevers A, de Vos RA, Jansen Steur EN, Lindstrom J, Pilz K, Nowacki S, Bloch W, Schroder H (2000) Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach. Neurobiol Dis 7:666-672. Berg DK, Conroy WG (2002) Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J Neurobiol 53:512-523. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234-258. Brandon NJ, Handford EJ, Schurov I, Rain JC, Pelling M, Duran-Jimeniz B, Camargo LM, Oliver KR, Beher D, Shearman MS, Whiting PJ (2004) Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 25:42-55. Breese CR, Logel J, Adams C, Leonard SS (1996) Regional gene expression of the glutamate receptor subtypes GluR1, GluR2, and GluR3 in human postmortem brain. J Mol Neurosci 7:277-289. Breese CR, Adams C, Logel J, Drebing C, Rollins Y, Barnhart M, Sullivan B, Demasters BK, Freedman R, Leonard S (1997) Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387:385-398. Brioni JD, O'Neill AB, Kim DJ, Decker MW (1993) Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 238:1-8. Buchsbaum MS (1990) The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 16:379-389. Burdick KE, Hodgkinson CA, Szeszko PR, Lencz T, Ekholm JM, Kane JM, Goldman D, Malhotra AK (2005) DISC1 and neurocognitive function in schizophrenia. Neuroreport 16:1399-1402. Burghaus L, Schutz U, Krempel U, de Vos RA, Jansen Steur EN, Wevers A, Lindstrom J, Schroder H (2000) Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res Mol Brain Res 76:385-388. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL (2000) Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry 157:1660-1668. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 102:8627-8632. Cannon TD (2005) The inheritance of intermediate phenotypes for schizophrenia. Curr Opin Psychiatry 18:135-140. Cannon TD, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen M, Gasperoni T, Tuulio-Henriksson A, Pirkola T, Toga AW, Kaprio J, Mazziotta J, Peltonen L (2005) Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 62:1205-1213. Carlsson A, Hansson LO, Waters N, Carlsson ML (1999) A glutamatergic deficiency model of schizophrenia. Br J Psychiatry Suppl:2-6. Cecil KM, Lenkinski RE, Gur RE, Gur RC (1999) Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20:131-140. Chelelgo J, Haverinen U, Vahteristo M, Koivisto J, Husman T, Nevalainen A, Jaaskelainen E (2001) Analysis of moisture findings in the interior spaces of Finnish housing stock. J Air Waste Manag Assoc 51:69-77. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54:387-402. Cohen JD, Servan-Schreiber D (1993) A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophr Bull 19:85-104. Conroy WG, Berg DK (1998) Nicotinic receptor subtypes in the developing chick brain: appearance of a species containing the alpha4, beta2, and alpha5 gene products. Mol Pharmacol 53:392-401. Cooper E, Couturier S, Ballivet M (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350:235-238. Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E (1999) Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem 73:1590-1597. Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365-384. Coyle JT, Tsai G, Goff D (2003) Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 1003:318-327. Crosson B, Hughes CW (1987) Role of the thalamus in language: is it related to schizophrenic thought disorder? Schizophr Bull 13:605-621. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38:120-134. Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155:1490-1501. Darsow T, Booker TK, Pina-Crespo JC, Heinemann SF (2005) Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors. J Biol Chem 280:18311-18320. de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ (2002) Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res 56:55-65. Eastwood SL (2004) The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol 59:47-72. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S (1994) Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79:705-715. Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J (2001) alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci U S A 98:3501-3506. Flattem NL, Blakely RD (2000) Modified structure of the human serotonin transporter promoter. Mol Psychiatry 5:110-115. Freedman R (2003) Schizophrenia. N Engl J Med 349:1738-1749. Freedman R, Adams CE, Leonard S (2000) The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J Chem Neuroanat 20:299-306. Freedman R, Hall M, Adler LE, Leonard S (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33. Gasperoni TL, Ekelund J, Huttunen M, Palmer CG, Tuulio-Henriksson A, Lonnqvist J, Kaprio J, Peltonen L, Cannon TD (2003) Genetic linkage and association between chromosome 1q and working memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 116B:8-16. Geyer MA, McIlwain KL, Paylor R (2002) Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 7:1039-1053. Goldman-Rakic PS (1995) Architecture of the prefrontal cortex and the central executive. Ann N Y Acad Sci 769:71-83. Gotti C, Moretti M, Longhi R, Briscini L, Balestra B, Clementi F (1994a) Expression of alpha-bungarotoxin receptor subtypes in chick central nervous system during development. J Recept Res 14:335-346. Gotti C, Hanke W, Maury K, Moretti M, Ballivet M, Clementi F, Bertrand D (1994b) Pharmacology and biophysical properties of alpha 7 and alpha 7-alpha 8 alpha-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur J Neurosci 6:1281-1291. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15-20. Greger IH, Ziff EB, Penn AC (2007) Molecular determinants of AMPA receptor subunit assembly. Trends Neurosci 30:407-416. Gregor P, Reeves RH, Jabs EW, Yang X, Dackowski W, Rochelle JM, Brown RH, Jr., Haines JL, O'Hara BF, Uhl GR, et al. (1993) Chromosomal localization of glutamate receptor genes: relationship to familial amyotrophic lateral sclerosis and other neurological disorders of mice and humans. Proc Natl Acad Sci U S A 90:3053-3057. Grimwood S, Slater P, Deakin JF, Hutson PH (1999) NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 10:461-465. Guan ZZ, Zhang X, Blennow K, Nordberg A (1999) Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 10:1779-1782. Guan ZZ, Zhang X, Ravid R, Nordberg A (2000) Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74:237-243. Hamera E, Schneider JK, Deviney S (1995) Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 183:559-565. Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 ( Pt 4):593-624. Hazlett EA, Romero MJ, Haznedar MM, New AS, Goldstein KE, Newmark RE, Siever LJ, Buchsbaum MS (2007) Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr Res 93:288-295. Hennah W, Tuulio-Henriksson A, Paunio T, Ekelund J, Varilo T, Partonen T, Cannon TD, Lonnqvist J, Peltonen L (2005) A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol Psychiatry 10:1097-1103. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A (2007) Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 104:14501-14506. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, Malhotra AK (2004) Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 75:862-872. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108. Hung SY, Huang WP, Liou HC, Fu WM (2009) Autophagy protects neuron from Abeta-induced cytotoxicity. Autophagy 5. Hunt S, Schmidt J (1979) The relationship of alpha-bungarotoxin binding activity and cholinergic termination within the rat hippocampus. Neuroscience 4:585-592. Irvine EE, Cheeta S, File SE (1999) Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 10:691-697. Irvine EE, Cheeta S, File SE (2001a) Development of tolerance to nicotine's anxiogenic effect in the social interaction test. Brain Res 894:95-100. Irvine EE, Cheeta S, Marshall M, File SE (2001b) Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects. Pharmacol Biochem Behav 68:769-776. Ishizuka K, Paek M, Kamiya A, Sawa A (2006) A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry 59:1189-1197. James R, Adams RR, Christie S, Buchanan SR, Porteous DJ, Millar JK (2004) Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci 26:112-122. Jarrard LE (1995) What does the hippocampus really do? Behav Brain Res 71:1-10. Javitt DC (1987) Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 9:12-35. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308. Jayanthi LD, Ramamoorthy S (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7:E728-738. Jonnala RR, Graham JH, 3rd, Terry AV, Jr., Beach JW, Young JA, Buccafusco JJ (2003) Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. Synapse 47:262-269. Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y, Sawamura N, Park U, Kudo C, Okawa M, Ross CA, Hatten ME, Nakajima K, Sawa A (2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7:1167-1178. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736. Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7:837-844. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A (2001) alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276:13541-13546. Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, Roberts RC (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 497:436-450. Koike H, Arguello PA, Kvajo M, Karayiorgou M, Gogos JA (2006) Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc Natl Acad Sci U S A 103:3693-3697. Komuro H, Rakic P (1996) Intracellular Ca2+ fluctuations modulate the rate of neuronal migration. Neuron 17:275-285. Konradi C, Heckers S (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 97:153-179. Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, Abi-Saab W, Madonick S (1999) NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 7:125-143. Kumari V, Soni W, Sharma T (2001) Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 16:321-326. Kumari V, Das M, Zachariah E, Ettinger U, Sharma T (2005) Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology 42:588-594. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20:687-702. Le Novere N, Zoli M, Changeux JP (1996) Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8:2428-2439. Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, Olincy A, Freedman R (1998a) Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci 12:195-201. Leonard S, Gault J, Moore T, Hopkins J, Robinson M, Olincy A, Adler LE, Cloninger CR, Kaufmann CA, Tsuang MT, Faraone SV, Malaspina D, Svrakic DM, Freedman R (1998b) Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. Am J Med Genet 81:308-312. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, Gault J, Lee MJ, Logel J, Olincy A, Ross RG, Stevens K, Sullivan B, Vianzon R, Virnich DE, Waldo M, Walton K, Freedman R (2001) Smoking and mental illness. Pharmacol Biochem Behav 70:561-570. Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology (Berl) 108:417-431. Levin ED (2002) Nicotinic receptor subtypes and cognitive function. J Neurobiol 53:633-640. Lewis DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409-432. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324. Li Q (2006) Cellular and molecular alterations in mice with deficient and reduced serotonin transporters. Mol Neurobiol 34:51-66. Lieberman JA, Kinon BJ, Loebel AD (1990) Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16:97-110. Lindstrom J (1996) Neuronal nicotinic acetylcholine receptors. Ion Channels 4:377-450. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR (2003) Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci 18:391-402. Liu YL, Fann CS, Liu CM, Chen WJ, Wu JY, Hung SI, Chen CH, Jou YS, Liu SK, Hwang TJ, Hsieh MH, Ouyang WC, Chan HY, Chen JJ, Yang WC, Lin CY, Lee SF, Hwu HG (2006) A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attention. Biol Psychiatry 60:554-562. Maccioni RB, Cambiazo V (1995) Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev 75:835-864. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94:507-514. Marenco S, Weinberger DR (2000) The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 12:501-527. Martin LJ, Furuta A, Blackstone CD (1998) AMPA receptor protein in developing rat brain: glutamate receptor-1 expression and localization change at regional, cellular, and subcellular levels with maturation. Neuroscience 83:917-928. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82:4245-4249. Mayer ML (2005) Glutamate receptor ion channels. Curr Opin Neurobiol 15:282-288. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD, Folstein SE, Haines JL, Sutcliffe JS (2004) Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet B Neuropsychiatr Genet 127B:104-112. Millar JK, Christie S, Porteous DJ (2003) Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem Biophys Res Commun 311:1019-1025. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, Clair DM, Muir WJ, Blackwood DH, Porteous DJ (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415-1423. Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, Malloy MP, Chubb JE, Huston E, Baillie GS, Thomson PA, Hill EV, Brandon NJ, Rain JC, Camargo LM, Whiting PJ, Houslay MD, Blackwood DH, Muir WJ, Porteous DJ (2005) DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310:1187-1191. Miyoshi K, Asanuma M, Miyazaki I, Diaz-Corrales FJ, Katayama T, Tohyama M, Ogawa N (2004) DISC1 localizes to the centrosome by binding to kendrin. Biochem Biophys Res Commun 317:1195-1199. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, Fujita T, Kuroda S, Katayama T, Tohyama M (2003) Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 8:685-694. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221. Morris JA, Kandpal G, Ma L, Austin CP (2003) DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 12:1591-1608. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY (2002) Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110:199-211. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603. Nashmi R, Dickinson ME, McKinney S, Jareb M, Labarca C, Fraser SE, Lester HA (2003) Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J Neurosci 23:11554-11567. Neve RL, Robakis NK (1998) Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci 21:15-19. Nolte S, Wong D, Lachford G (2004) Amphetamines for schizophrenia. Cochrane Database Syst Rev:CD004964. Nordberg A (1994) Human nicotinic receptors--their role in aging and dementia. Neurochem Int 25:93-97. Nuutinen S, Ekokoski E, Lahdensuo E, Tuominen RK (2006) Nicotine-induced upregulation of human neuronal nicotinic alpha7-receptors is potentiated by modulation of cAMP and PKC in SH-EP1-halpha7 cells. Eur J Pharmacol 544:21-30. Oda Y (1999) Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 49:921-937. Olincy A, Young DA, Freedman R (1997) Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 42:1-5. Ouagazzal AM, Kenny PJ, File SE (1999) Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology (Berl) 144:54-60. Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K, Okawa M, Yamada N, Hatten ME, Snyder SH, Ross CA, Sawa A (2003) Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100:289-294. Pantelis C, Barnes TR, Nelson HE (1992) Is the concept of frontal-subcortical dementia relevant to schizophrenia? Br J Psychiatry 160:442-460. Paunio T, Tuulio-Henriksson A, Hiekkalinna T, Perola M, Varilo T, Partonen T, Cannon TD, Lonnqvist J, Peltonen L (2004) Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q. Hum Mol Genet 13:1693-1702. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A (1998) Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem 5:302-316. Paz RD, Tardito S, Atzori M, Tseng KY (2008) Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol 18:773-786. Peng X, Katz M, Gerzanich V, Anand R, Lindstrom J (1994) Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol 45:546-554. Perry TL, Kish SJ, Buchanan J, Hansen S (1979) Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet 1:237-239. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, Ross CA (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 13:173-186, 115. Porteous DJ, Millar JK (2006) Disrupted in schizophrenia 1: building brains and memories. Trends Mol Med 12:255-261. Potier MC, Spillantini MG, Carter NP (1992) The human glutamate receptor cDNA GluR1: cloning, sequencing, expression and localization to chromosome 5. DNA Seq 2:211-218. Powers RE (1999) The neuropathology of schizophrenia. J Neuropathol Exp Neurol 58:679-690. Puckett C, Gomez CM, Korenberg JR, Tung H, Meier TJ, Chen XN, Hood L (1991) Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proc Natl Acad Sci U S A 88:7557-7561. Qi XL, Nordberg A, Xiu J, Guan ZZ (2007) The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease. Neurochem Int 51:377-383. Radant AD, Bowdle TA, Cowley DS, Kharasch ED, Roy-Byrne PP (1998) Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? Neuropsychopharmacology 19:434-444. Raedler TJ, Knable MB, Weinberger DR (1998) Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 8:157-161. Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, Role L (1996) Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature 380:347-351. Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL (1989) Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci 45:1065-1072. Reynolds GP, Czudek C, Andrews HB (1990) Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry 27:1038-1044. Rezvani AH, Levin ED (2001) Cognitive effects of nicotine. Biol Psychiatry 49:258-267. Ripoll N, Bronnec M, Bourin M (2004) Nicotinic receptors and schizophrenia. Curr Med Res Opin 20:1057-1074. Robbins TW (1990) The case of frontostriatal dysfunction in schizophrenia. Schizophr Bull 16:391-402. Roberts RC (2007) Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr Bull 33:11-15. Role LW, Berg DK (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52:139-153. Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL (2005) A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry 10:758-764. Salas R, Pieri F, Fung B, Dani JA, De Biasi M (2003) Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci 23:6255-6263. Sallette J, Bohler S, Benoit P, Soudant M, Pons S, Le Novere N, Changeux JP, Corringer PJ (2004) An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J Biol Chem 279:18767-18775. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443. Sawamura N, Sawa A (2006) Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses. Ann N Y Acad Sci 1086:126-133. Sawamura N, Sawamura-Yamamoto T, Ozeki Y, Ross CA, Sawa A (2005) A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc Natl Acad Sci U S A 102:1187-1192. Schuller HM (2009) Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9:195-205. Schurov IL, Handford EJ, Brandon NJ, Whiting PJ (2004) Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol Psychiatry 9:1100-1110. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6:487-498. Selkoe DJ (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453. Shen S, Lang B, Nakamoto C, Zhang F, Pu J, Kuan SL, Chatzi C, He S, Mackie I, Brandon NJ, Marquis KL, Day M, Hurko O, McCaig CD, Riedel G, St Clair D (2008) Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 28:10893-10904. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Malinow R (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 284:1811-1816. Snyder SH (1973) Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. Am J Psychiatry 130:61-67. Snyder SH (2006) Dopamine receptor excess and mouse madness. Neuron 49:484-485. Song I, Huganir RL (2002) Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 25:578-588. Squire LR, Zola SM (1996) Structure and function of declarative and nondeclarative memory systems. Proc Natl Acad Sci U S A 93:13515-13522. Srinivasan TN, Thara R (2002) Smoking in schizophrenia -- all is not biological. Schizophr Res 56:67-74. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ (1990) Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336:13-16. Stevens CF, Sullivan J (1998) Synaptic plasticity. Curr Biol 8:R151-153. Stolerman IP, Mirza NR, Shoaib M (1995) Nicotine psychopharmacology: addiction, cognition and neuroadaptation. Med Res Rev 15:47-72. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL (2006) Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 63:1325-1335. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhan | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43089 | - |
dc.description.abstract | Disrupted-in-Schizophrenia 1 (DISC1)是精神分裂症和其他精神疾病中被認為最常見的致病基因,它在一個蘇格蘭家族中首度被發現有balanced chromosomal translocation (1; 11) (q42.1; q14.3)而使DISC1發生斷裂。另一方面,α7 nicotinic receptor (α7 nAChR)已知和很多行為有關,包括認知方面的功能。在精神分裂症死後病人的腦部一些區域已發現α7 nAChRs的表現有缺陷,基因的研究結果也顯示α7 nAChRs和精神分裂症有關。因此本篇論文將探討DISC1 (1-597 a.a.)和α7 nAChR之間的關係。我們在人類神經瘤細胞株SH-SY5Y轉殖mutant DISC1 (C-terminal truncation, 1-597 a.a.),發現mutant DISC1可以減少α7 nAChR mRNA和蛋白的表現。另外,C57BL/6J;129S6/SvEv (B6/Sv129)交配之小鼠已被發現在單股染色體之DISC1有發生變異,同時我們也發現將B6/Sv129胎鼠(E18)的cortex急性取下,其α7 nAChRs表現量減少。先前我們已有實驗證實α7 nAChRs會透過autophagosome的途徑參與Aβ的清除,因此我們透過B6/Sv129小鼠的primary cortical culture去研究DISC1變異對Aβ產生的神經毒性有無影響,在此我們發現給予Aβ1-42之後,heterozygous (+/-) B6/Sv129小鼠的primary culture發現有較少的NeuN (+) 細胞,此結果顯示有DISC1變異會導致Aβ1-42的神經毒性增加,也暗示DISC1變異可能在精神分裂症中對於認知功能障礙扮演一個重要的角色。我們更進一步觀察B6/Sv129成鼠的各個區域受體的表現,發現和wild-type小鼠相比,在heterozygous (+/-) B6/Sv129小鼠的striatum有表現較少的α7 nAChRs;在amygdale和striatum有表現較少的ChAT。此結果也可以部分解釋在shuttle avoidance test中heterozygous (+/-) B6/Sv129小鼠和wild-type小鼠相比有較差的恐懼學習的表現。此外,在EPM test中,我們也發現急性給予nicotine對wild-type小鼠有anxiogenic的作用,但是在heterozygous (+/-) B6/Sv129小鼠anxiogenic作用減低。在PPI test中,我們發現不管是公鼠或母鼠,wild-type和heterozygous (+/-) B6/Sv129小鼠的驚嚇反應都沒有顯著差異。
此結果顯示DISC1可以影響cholinergic system,進而影響情緒、認知及精神疾病相關症狀。 | zh_TW |
dc.description.abstract | Disrupted-in-Schizophrenia 1 (DISC1) is one of the most promising risk genes for schizophrenia and other major mental disorders, which is disrupted by a balanced chromosomal translocation (1; 11) (q42.1; q14.3) in a large Scottish family. On the other hand, α7 nicotinic receptor (α7 nAChR) is well-known to be involved in a wide variety of behavioral functions including cognition. Post-mortem studies have revealed a disturbance of α7 nAChRs expression in various cerebral areas in schizophrenia patients. Genetic linkage studies have also shown that the α7 subunit is involved in schizophrenia. In this study, we investigated the relationship between DISC1 (1-597 a.a.) and α7 nAChR. It was found that transfection of mutant DISC1 (C-terminal truncation, 1-597 a.a.) in human neuroblastoma cells, SH-SY5Y, significantly inhibited the mRNA and protein expression of α7 nAChR. In addition, the acutely isolated cortex from fetal heterozygous (+/-) C57BL/6J; 129S6/SvEv (B6/Sv129) mice (E18), which have DISC1 gene mutation, had less expression of α7 nAChRs. Previously, we have found that α7 nAChR is involved in the clearance of Aβ via autophagosome process. We thus examined the effect of mutant DISC1 on the Aβ-induced neuronal death by using primary cortex neuronal culture. It was found that there were more NeuN (+) cells in primary cortical culture derived from wild-type mice than in heterozygous (+/-) B6/Sv129 mice. This result indicated that DISC1 mutation is more sensitive to Aβ1-42–induced neuronal toxicity and may play a role in cognition impairment in schizophrenia. Furthermore, we also found that there were more α7 nAChRs in the striatum, more ChAT protein expression in the amygdale and striatum from adult wild-type than in heterozygous (+/-) B6/Sv129 mice. This result may partially explain that the heterozygous (+/-) B6/Sv129 mice had impairment in fear-memory of shuttle avoidance test. In addition, we also found that acute administration of nicotine exerted anxiogenic effect and the effect was reduced in heterozygous (+/-) B6/Sv129 mice. There was no significant difference of startle response in response to prepulse inhibition test between wild-type and heterozygous (+/-) B6/Sv129 mice.
In conclusion, our results demonstrated that influence on cholinergic system may be involved in the impairment of emotion, cognition following the defect of DISC1. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:36:22Z (GMT). No. of bitstreams: 1 ntu-98-R96443012-1.pdf: 2335077 bytes, checksum: 744651227f9a9488fc006650be975a99 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | Abbreviation.............................................................................................Ⅰ
中文摘要..................................................................................................Ⅳ Abstract....................................................................................................Ⅵ Introduction................................................................................................1 1.1 Schizophrenia.......................................................................................1 1.2 Disrupted-in-Schizophrenia 1 (DISC1)..................................................4 1.3 α7 nicotinic receptor (α7 nAChR).....................................................8 1.4 C57BL/6J;129S6/SvEv (B6/Sv129) mice..............................................13 Materials and methods.................................................................................20 2.1 Materials................................................................................................20 2.2 Methods................................................................................................20 Results........................................................................................................31 3.1 Decrease of normal DISC1 protein by the transfection of mutant DISC1 (1-597a.a) in SH-SY5Y cells......................................................31 3.2 Down-regulation of full-length DISC1 protein decreases neurite outgrowth in differentiated SH-SY5Y cells.............................................31 3.3 Decrease of mRNA and protein levels of α7 nAChR by mutant DISC1 in SH-SY5Y cells......................................................32 3.4 Decrease of α3 nAChR protein expression by mutant DISC1 transfection in SH-SY5Y cells......................................................33 3.5 Decrease of α7 nAChR protein expression in acutely isolated cortex of fetal heterozygous (+/-) B6/Sv129 mice........................................33 3.6 Decrease of α7 nAChR enhances Aβ-induced neurotoxicity in primary cortical neuron of heterozygous (+/-) B6/Sv129 mic...................34 3.7 Decrease of α7 nAChR, but not α3 nAChR protein expression in the striatum of heterozygous (+/-) B6/Sv129 mice................................36 3.8 Decrease of ChAT protein expression in the amygdale and striatum of heterozygous (+/-) B6/Sv129 mice...................................................37 3.9 No difference of NR2B protein expression between heterozygous (+/-) B6/Sv129 mice and wild-type controls............................................38 3.10 No difference of GluR1 protein expression between heterozygous (+/-) B6/Sv129 mice and wild-type controls..........................................40 3.11 No difference of SERT protein expression between heterozygous (+/-) B6/Sv129 mice and wild-type controls...........................................41 3.12 Inhibition of shuttle-avoidance learning in heterozygous (+/-) B6/Sv129 mice………………………………............................................42 3.13 Inhibition of nicotine action in heterozygous (+/-) B6/Sv129 mice following elevated plus maze (EPM) test.............................................42 3.14 No prepulse inhibition (PPI) in heterozygous (+/-) B6/Sv129 mice............................................................................................................43 Discussion……………………………………………………………47 Figure and legend……………………………………………………52 Reference………………………………………………………………71 | |
dc.language.iso | en | |
dc.title | 精神分裂症致病基因DISC1變異對α7 nicotinic receptor表現之探討 | zh_TW |
dc.title | Effect of Schizophrenia-related DISC1 defect on α7 nicotinic receptor expression | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 尹相姝,楊春茂,嚴震東,簡伯武 | |
dc.subject.keyword | 阿法7號尼古丁乙醯膽鹼受體,澱粉乙型蛋白,C57BL/6J,129S6/SvEv (B6/Sv129) mice,Disrupted-in-Schizophrenia 1 (DISC1), | zh_TW |
dc.subject.keyword | α7 nicotinic receptor (α7 nAChR),β-amyloid (Aβ),C57BL/6J,129S6/SvEv (B6/Sv129) mice,Disrupted-in-Schizophrenia 1 (DISC1), | en |
dc.relation.page | 85 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-16 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 2.28 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。